4.5 Review

Asthma in pregnancy - Immunological changes and clinical management

期刊

RESPIRATORY MEDICINE
卷 105, 期 2, 页码 159-164

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.rmed.2010.11.006

关键词

Asthma; Clinical implications; Immunology; Management; Pregnancy

资金

  1. Hungarian Respiratory Society
  2. Aerocrine
  3. Merck
  4. Genentech
  5. GlaxoSmithKline

向作者/读者索取更多资源

Asthma is one of the most common diseases complicating pregnancy and a risk factor for several maternal and fetal complications, posing a special challenge for physicians treating asthmatic pregnant women. Asthma influences the outcome of pregnancy and vice versa pregnancy affects asthma severity with bidirectional immunological interactions that are currently being examined. Supporting pregnancy-induced immunotolerance is the observation that attenuation of allergic responses can be detected in controlled asthmatic pregnant patients. However, uncontrolled asthmatic pregnant women show significant asthma-associated immune reactions, such as diminished pregnancy specific regulatory T cell proliferation, that may besides other factors influence fetal growth. Uncontrolled, symptomatic asthma may increase the risk of adverse perinatal outcomes; thus adequate regular anti-asthmatic treatment resulting in optimal asthma control represents a vital need during pregnancy. This review summarizes immunological changes characterizing pregnancy in asthmatic women together with the clinical implications of asthma management during pregnancy. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据